Aura Biosciences, Inc. Stock Analysis & AI Score
Aura Biosciences, Inc. (AURA) has an ST Score of 54.3 (B-), driven by its Forecast (A) and held back by its Growth (D+). Analysts rate it Buy with a $17.50 price target (+184.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Aura Biosciences, Inc. (AURA) has an ST Score of 54.3 (B-), driven by its Forecast (A) and held back by its Growth (D+). Analysts rate it Buy with a $17.50 price target (+184.6% upside).
- Strongest
- ForecastA
- Weakest
- GrowthD+
All factor grades
- ForecastA
- ValuationA-
- Financial StrengthB
- MomentumB-
- ProfitabilityC+
- GrowthD+
- Piotroski2/9
Contact
AURA stock: frequently asked questions
What is AURA's ST Score?
Aura Biosciences, Inc. (AURA) has an ST Score of 54.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AURA a buy, hold, or sell?
Analysts rate AURA a Buy, with a price target of $17.50 (+184.6% vs the current price). Our ST Score grades it B- (54.3/100). The ST Score is a data-driven signal, not a recommendation.
What are AURA's factor grades?
Valuation A-, Profitability C+, Financial Strength B, Momentum B-, Growth D+, Forecast A.
What is AURA's valuation grade?
Aura Biosciences, Inc. (AURA) earns a valuation grade of A-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AURA's growth grade?
Aura Biosciences, Inc. (AURA) earns a growth grade of D+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AURA's profitability grade?
Aura Biosciences, Inc. (AURA) earns a profitability grade of C+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AURA's financial strength grade?
Aura Biosciences, Inc. (AURA) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AURA?
The average analyst price target for Aura Biosciences, Inc. (AURA) is $17.50 from 8 analysts, which is +184.6% versus the recent price of $6.15.
What is AURA's Piotroski score?
Aura Biosciences, Inc. (AURA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.